An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo (original) (raw)

Nature Genetics volume 33, pages 396–400 (2003)Cite this article

Abstract

The application of RNA interference (RNAi) to mammalian systems has the potential to revolutionize genetics and produce novel therapies. Here we investigate whether RNAi applied to a well-characterized gene can stably suppress gene expression in hematopoietic stem cells and produce detectable phenotypes in mice. Deletion of the Trp53 tumor suppressor gene greatly accelerates _Myc_-induced lymphomagenesis, resulting in highly disseminated disease1,2. To determine whether RNAi suppression of Trp53 could produce a similar phenotype, we introduced several Trp53 short hairpin RNAs (shRNAs) into hematopoietic stem cells derived from Eμ-Myc transgenic mice, and monitored tumor onset and overall pathology in lethally irradiated recipients. Different Trp53 shRNAs produced distinct phenotypes in vivo, ranging from benign lymphoid hyperplasias to highly disseminated lymphomas that paralleled Trp53 −/− lymphomagenesis in the Eμ-Myc mouse. In all cases, the severity and type of disease correlated with the extent to which specific shRNAs inhibited p53 activity. Therefore, RNAi can stably suppress gene expression in stem cells and reconstituted organs derived from those cells. In addition, intrinsic differences between individual shRNA expression vectors targeting the same gene can be used to create an 'epi-allelic series' for dissecting gene function in vivo.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Schmitt, C.A., McCurrach, M.E., de Stanchina, E., Wallace-Brodeur, R.R. & Lowe, S.W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670–2677 (1999).
    Article CAS Google Scholar
  2. Schmitt, C.A. et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1, 289–298 (2002).
    Article CAS Google Scholar
  3. Hannon, G.J. RNA interference. Nature 418, 244–251 (2002).
    Article CAS Google Scholar
  4. Knight, S.W. & Bass, B.L. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 293, 2269–2271 (2001).
    Article CAS Google Scholar
  5. Ketting, R.F. et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15, 2654–2659 (2001).
    Article CAS Google Scholar
  6. Hutvagner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001).
    Article CAS Google Scholar
  7. Grishok, A. et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106, 23–34 (2001).
    Article CAS Google Scholar
  8. Paddison, P.J. & Hannon, G.J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17–23 (2002).
    Article CAS Google Scholar
  9. Attardi, L.D. & Jacks, T. The role of p53 in tumour suppression: lessons from mouse models. Cell. Mol. Life Sci. 55, 48–63 (1999).
    Article CAS Google Scholar
  10. Evan, G.I. & Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348 (2001).
    Article CAS Google Scholar
  11. Adams, J.M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533–538 (1985).
    Article CAS Google Scholar
  12. Zilfou, J.T., Hoffman, W.H., Sank, M., George, D.L. & Murphy, M. The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol. Cell. Biol. 21, 3974–3985 (2001).
    Article CAS Google Scholar
  13. McCurrach, M.E. & Lowe, S.W. Methods for studying pro- and antiapoptotic genes in nonimmortal cells. Methods Cell Biol. 66, 197–227 (2001).
    Article CAS Google Scholar
  14. Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P.P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat. Genet. 27, 222–224 (2001).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank J. Adams and T. Jacks for providing mice, and C. Rosenthal, M. E. Dudas, and M. S. Jiao for invaluable technical assistance. P.J.P. is an Arnold and Mabel Beckman Fellow of the Watson School of Biological Sciences. G.J.H. is a Rita Allen Foundation Scholar and is supported by an Innovator award from the U.S. Army Breast Cancer Research Program. This work was supported by US National Cancer Institute (NCI) postdoctoral training grants (M.T.H. and J.T.Z.), program project grants (C.C.C., G.J.H. and S.W.L.) from the NCI, and a generous gift from the Ann L. and Herbert J. Siegel Philanthropic Fund.

Author information

Authors and Affiliations

  1. Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, 11724, New York, USA
    Michael T. Hemann, Jordan S. Fridman, Jack T. Zilfou, Patrick J. Paddison, Gregory J. Hannon & Scott W. Lowe
  2. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Eva Hernando & Carlos Cordon-Cardo

Authors

  1. Michael T. Hemann
  2. Jordan S. Fridman
  3. Jack T. Zilfou
  4. Eva Hernando
  5. Patrick J. Paddison
  6. Carlos Cordon-Cardo
  7. Gregory J. Hannon
  8. Scott W. Lowe

Corresponding authors

Correspondence toGregory J. Hannon or Scott W. Lowe.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Hemann, M., Fridman, J., Zilfou, J. et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.Nat Genet 33, 396–400 (2003). https://doi.org/10.1038/ng1091

Download citation